Google Health Connect has paired up with Proov - a platform that offers hormone and fertility information through its at-home tests and the Proov Insights app that can help avoid costly, invasive procedures like in vitro fertilization (IVF).
The pairing will provide the ‘only FDA-cleared and CE marked at-home ovulation diagnostic platform’.
As per the report, the Proov system tracks up to ‘four hormones to discover an expanded six days of fertility, hormone imbalances and insights into health conditions like painful PMS and repeated miscarriages. Users can even learn how many eggs they have left.’
These insights can help users avoid costly IVF procedures and are unique due to its at-home nature.
By integrating Proov into the Google Health Connect ecosystem, multiple health insights can be created to understand how things like sleep relate to fertility and a menstruator's cycle.
The report states that the tool is billed by cycle and hormones. Progesterone-only tests are $29 per cycle; four hormone tests are $89 a cycle. This means a user conducts a urine test 20 times during their cycle to gain insights into how hormones fluctuate within their cycle. Proov recommends that menstruators complete three cycles of tests in order to rule out abnormalities like especially stressful months.
Follicle-stimulating hormone (FSH) is tested to check egg count. Progesterone (PdG) tests confirm successful ovulation. Estrogen (E1G) and luteinizing hormone (LH) measure which six days of the week are the best to attempt conception. By mapping out all four hormones, Proov can perform early screening for polycystic ovary disease (PCOS) which can cause many physical and hormonal imbalances.
Period tracking apps often only predict five days of fertility based on aggregated data that may not speak to an individual’s fertility window.
Join the HealthXL Masterclass on the ‘DTx Access Negotiation and Contracting with Commercial Health Plans in the US’ on 15th December. Click here to Request to Join.
Click here to read the original news article.